 BURBANK, Calif., July 08, 2021 GLOBE NEWSWIRE -- via NewMediaWire Medolife Rx, Inc. Medolife, a global integrated biopharmaceutical company with RD, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. OTC PINK: QNTA, announced today new clinical observations made on its lead drug candidate Escozine. 